“I mean, I’d love there to be a cure for cancer, but I do not believe them in the absence of good human evidence,” he said.
The company has not yet published any clinical evidence showing this treatment works in humans. CEO Ilan Morad told the Jerusalem Post that AEBi has only finished its first exploratory mice experiment, which he claims inhibited cancer cell growth.
The Food and Drug Administration, which declined to comment on the company’s treatment, has an extensive review process for drug approval in the United States: “Before a drug can be tested in people, the drug company or sponsor performs laboratory and animal tests to discover how the drug works and whether it’s likely to be safe and work well in humans. Next, a series of tests in people is begun to determine whether the drug is safe when used to treat a disease and whether it provides a real health benefit,” FDA says on its site.
The company acknowledged in an email to CNBC that “complete cure for cancer meaning that we will have the complete solution ready for first tryout in humans. A solution that is supposed to finish the problem without it coming back. Even in the unlikely event that it comes back it can be re-administeredre-adjusted.”
Aridor said the company’s first target is lung cancer and that it’s working on others.
from Just News Viral http://bit.ly/2ThxtXb
0 Comments